...
首页> 外文期刊>Journal of biomedical materials research, Part A >Precoating of biphasic calcium phosphate bone substitute with atelocollagen enhances bone regeneration through stimulation of osteoclast activation and angiogenesis
【24h】

Precoating of biphasic calcium phosphate bone substitute with atelocollagen enhances bone regeneration through stimulation of osteoclast activation and angiogenesis

机译:通过刺激破骨细胞活化和血管生成,通过刺激骨质再生,磷酸钙骨替代骨质替代品增强了骨再生

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Type I collagen (Col) is a naturally polymerizing protein and important extracellular matrix bone component. The aim of this study was to improve bone regeneration capacity by precoating the surface of biphasic calcium phosphate (BCP) granules with AT-Col, and evaluating its biological effects. BCP granules were precoated with AT-Col using adsorption and lyophilization method. Morphology of AT-Col precoated surfaces was observed using scanning electron microscopy (SEM). Biocompatibility and osteogenic activity of AT-Col were determined in vitro with human mesenchymal stem cell (hMSCs). In vivo bone healing efficiency and related biological effects were determined using a rabbit calvarial defect model. SEM results revealed numerous irregularly distributed AT-Col polymer clusters on BCP granule surface. Biocompatibility experiments demonstrated that AT-Col was non-cytotoxic, and that cell proliferation, adhesion, and osteogenic activity were improved by AT-Col precoating. After in vivo surgical implantation into bone defects, new bone formation was improved by AT-Col granule precoating. Specifically, 8 weeks post-surgery, percentage bone volume was significantly higher in AT-Col/BCP animals (35.02 +/- 1.89%) compared with BCP-treated animals (8.94 +/- 1.47%) (p<0.05). Furthermore, tartrate-resistant acid phosphatase staining and CD31 immunohistochemical staining revealed that osteoclast activation and new blood vessel formation in vivo were also induced by AT-Col precoating. Collectively, these data indicate that AT-Col/BCP may be potentially used as a bone substitute to enable effective bone regeneration through enhanced new blood vessel formation and osteoclast activation. (C) 2017 Wiley Periodicals, Inc.
机译:I型胶原(COL)是一种天然聚合的蛋白质和重要的细胞外基质骨组分。本研究的目的是通过在与AT-COL精确刻渐的双相磷酸钙(BCP)颗粒表面来改善骨再生能力,并评估其生物学效应。使用吸附和冻干方法将BCP颗粒预先用AT-Col预处理。使用扫描电子显微镜(SEM)观察在-COL预渗滤表面的形态。用人间充质干细胞(HMSCs)体外测定AT-COL的生物相容性和成骨活性。使用兔颅骨缺陷模型测定体内骨愈合效率和相关的生物学效果。 SEM结果显示了BCP颗粒表面上的许多不规则分布的AT-Col聚合物簇。生物相容性实验证明,在-COREAT中,在-COR是非细胞毒性,并且细胞增殖,粘附和骨质发生活性得到改善。在体内手术植入到骨缺损中,通过颗粒颗粒精细形成新的骨形成。具体地,手术后8周,与BCP处理的动物相比此外,耐酒型耐酸性酸性磷酸酶染色和CD31免疫组织化学染色表明,在-COLECORES中也诱导了体内骨质体激活和体内血管形成。总的来说,这些数据表明,通过增强的新血管形成和破骨细胞活化,可以将AT-COL / BCP潜在地用作骨骼再生以实现有效的骨再生。 (c)2017 Wiley期刊,Inc。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号